All companies
Visit website
3C Bio
Operating3C Bio, Inc.
Founded 2020
Mobile SARS-CoV-2 (COVID-19) diagnostic laboratories – 2,400 rtPCR tests per lab/day
Valuation cap ⓘ
$9.0M
As of Nov 2020 · from 3C Bio Convertible Note 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$55,275
Across 1 round since 2020
Latest share price
$1.00
3C Bio Convertible Note 1 offering price
Financials
FY2018–FY2019 · from SEC filings · hover any figure for its source$0
2018
$0
−$53K
2019
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
-$53,280
Taxes paid
$0
$0
Balance sheet
Cash
$0
$9,405
Accounts receivable
$0
$0
Total assets
$0
$9,415
Short-term debt
$0
$62,685
Long-term debt
$0
$0
Total liabilities
$0
$62,685
Other
Headcount
—
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$9.0M
Valuation cap
3C Bio Convertible Note 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $55.3K / $1.1MInvestors 102Valuation cap $9M
Reg CF annual-report compliance
Delinquent
Filed 0 of 6 annual reports (FY2020–FY2025)
Missing: 2020, 2021, 2022, 2023, 2024, 2025
102 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
- Form CJul 27, 20200001670254-20-000660EDGAR
Source: ManualCIK 0001818980Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.